NCT04129411View on ClinicalTrials.gov

Treatment of Papillary Thyroid Carcinoma With Radiofrequency Ablation

NACompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

June 15, 2020

Primary Completion Date

May 7, 2024

Study Completion Date

May 7, 2024

Conditions
Papillary Thyroid CancerPapillary Thyroid Microcarcinoma
Interventions
DEVICE

RFA

Radiofrequency ablation of selectively targeted thyroid nodule to treat papillary thyroid cancer.

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT04129411 - Treatment of Papillary Thyroid Carcinoma With Radiofrequency Ablation | Biotech Hunter | Biotech Hunter